Since 2008
Patent attorney at df-mp
Annette Hilgendorf
Partner
Dr. rer. nat., Dipl.-Biotech.
Dr. Hilgendorf joined df-mp in 2003 and is a member of the firm’s biotechnology and pharmaceuticals practice groups. She is authorized to represent clients before the German Patent and Trademark Office, the Unified Patent Court (UPC), the German Federal Patent Court, the European Patent Office as well as the European Intellectual Property Office.
+ 49 89 210 296 0
annette.hilgendorf@df-mp.com
Annette Hilgendorf
Partner
Dr. rer. nat., Dipl.-Biotech.
Dr. Hilgendorf joined df-mp in 2003 and is a member of the firm’s biotechnology and pharmaceuticals practice groups. She is authorized to represent clients before the German Patent and Trademark Office, the Unified Patent Court (UPC), the German Federal Patent Court, the European Patent Office as well as the European Intellectual Property Office.
+ 49 89 210 296 0
annette.hilgendorf@df-mp.com
practice areas.
Dr. Hilgendorf has a scientific background in both chemistry and biotechnology, in particular, in protein biochemistry, immunology, molecular biology and microbiology, as well as process engineering (cell culture techniques, microbial process engineering) and plant biotechnology. Dr. Hilgendorf's practice focuses on drafting and prosecution of patent applications. She has been involved in opposition proceedings before the European Patent Office and in providing opinions regarding infringement, validity and freedom-to-operate in the field of pharmaceuticals and biotechnology.
admissions.
- German Patent Attorney
- European Patent Attorney
- Unified Patent Court (UPC) representative
- European Trademark Attorney
- European Design Attorney
AWARDS AND RECOMMENDATIONS.
- Author of scientific papers on viral immune evasion mechanisms
curriculum vitae.
2007-2008
Trainee at the German Patent Office (DPMA) and the German Federal Patent Court (BPatG)
2003
Joined df-mp as a patent attorney candidate
1999-2003
Doctorate Degree in Biochemistry (magna cum laude) from the Ludwig-Maximilians-Universität München (dissertation on the modulation of cellular receptors upon viral infection, studies on the regulation of intracellular protein transport, cloning of whole adenovirus genomes in bacterial artificial chromosomes)
1999
Diplôme d’études approfondies (DEA) Biologie Moléculaire et Cellulaire at the Ecole Supérieure de Biotechnologie de Strasbourg — Université Louis Pasteur Strasbourg, France
1996-1999
Degree coursework (three years) in Biotechnology at the European Confederation of the Universities Basel, Freiburg, Karlsruhe and Strasbourg (EUCOR) and Diploma thesis at the University of Michigan, Ann Arbor (U.S.A.) in the field of cloning of adenoviral vectors for gene therapy Diplôme d’Ingénieur en Biotechnologie/Diplom in Biotechnologie (German, French and Swiss university degree)
1994-1996
Degree in Chemistry (Vordiplom Chemie) from the Ruprecht-Karls-Universität Heidelberg
association memberships.
publications.
- “Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptor“ A. Hilgendorf, J. Lindberg, Z. Ruszics, S. Höning, A. Elsing, M. Löfqvist, H. Engelmann, H.-G. Burgert (2003) Journal of Biological Chemistry Vol. 278, No. 51, pp. 51872-51884
- “Immune evasion by adenovirus E3 proteins: Exploitation of intracellular trafficking pathways”. M. Windheim, A. Hilgendorf and H.-G. Burgert (2004) Review in Current Topics in Microbiology and Immunology (CTMI) 273: 30-85.
- “Subversion of host defense mechanisms by adenoviruses” H.-G. Burgert, Z. Ruzsics, S. Obermeier, A. Hilgendorf, M. Windheim and A. Elsing (2002) Review in Current Topics in Microbiology and Immunology (CTMI) 269: 273-318.
YOUR PARTNER
For Patents. Trademarks. Designs.
df-mp Patentanwälte Rechtsanwälte PartG mbB © 2025 df-mp | Your partner for Patents. Trademarks. Designs. All Rights Reserved.
